|
Jul
21
FREE WHITE PAPER — 2026–2027 U.S. SUPPLEMENT OUTLOOK
From Me-Too to Defensible: Product development, sourcing and quality strategy for supplement brands who want to survive past the first order.
By NaturPro Scientific LLC and Fearless Naturals USA · July 2026
SUMMARY: The market does not need more products that merely look premium. It needs products that hold together. See why crowded categories, ingredient shortages and AI-generated brands are raising — not lowering — the bar for what makes a defensible product.
Complete the form below for the download link:
Mobile Access: https://243728998.fs1.hubspotusercontent-na2.net/hubfs/243728998/NaturPro%20Market%20Outlook%202026-2027.pdf
Jul
16
Ashwagandha Alliance, Safeguard Ashwagandha Present Science in EU Parliament
July 16, 2026
NaturPro Scientific Founder and President Blake Ebersole presented on behalf of the Ashwagandha Standards Alliance for policymakers at the European Parliament in Brussels.
The meeting, held by Safeguard Ashwagandha and Kerry Group to present scientific data on ashwagandha, brought together scientists, regulatory experts, industry leaders and retailers as Europe considers a possible formal assessment of ashwagandha, known as Article 8.
At the meeting, Dr. Thomas Brendler presented a review covering 131 clinical trial reports and toxicological assessments. A central conclusion was that the safety concerns repeatedly cited by authorities are not supported by the full body of current evidence.
The primary challenge is not safety, but compliance problems that the regulations are already established for.
As Alliance co-founding member Blake Ebersole shared with meeting participants, “What we are dealing with is not a question of safety, but a question of quality, standards and proper labeling.”
“While it’s true that some ashwagandha products are mislabeled as to plant part — in order to reach a number on the label — regulations already require accurate plant part and potency labels.”
The Alliance supports rigorous safety evaluation, GMP compliance, truthful plant-part and potency labeling, appropriate warnings, meaningful chemical characterization and evidence that applies to the actual product being sold.
“Safeguard Ashwagandha and Kerry deserve credit for moving the global discussion toward a harmonized, truthful and evidence-based approach.”
——
Reference: Ashwagandha armed with critical safety data as industry anticipates Europe-wide assessment, by Nikki Hancocks, Nutraingredients.com, July 16, 2026
Get involved with the Alliance today: https://ashwagandhastandards.org/join-the-alliance/